Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 9, 2006
The proteasome: a novel target for anticancer therapyC Montagut, A Rovira, J AlbanellCritical Reviews in Oncology/Hematology|August 30, 2008
Prostate cancer. Multidisciplinary approach: a key to successC Montagut, J Albanell, J BellmuntDrugs of Today (Barcelona, Spain : 1998)|August 6, 2005
Preclinical and clinical development of the proteasome inhibitor bortezomib in cancer treatmentC Montagut, A Rovira, B Mellado, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 10, 2011
Phase II trial of preoperative chemoradiotherapy with oxaliplatin, cisplatin, and 5-FU in locally advanced esophageal and gastric cancerM Pera, R Gallego, C Montagut, et al.Investigational New Drugs|May 23, 2012
A phase I, dose-finding study of sunitinib combined with cisplatin and 5-fluorouracil in patients with advanced gastric cancerC Gómez-Martín, R Salazar, C Montagut, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 7, 2023
High accuracy of a blood ctDNA-based multimodal test to detect colorectal cancerX Bessa, J Vidal, J C Balboa, et al.Oncology|July 16, 2005
Serum protein s-100 predicts clinical outcome in patients with melanoma treated with adjuvant interferon--comparison with tyrosinase rt-PCRJ Domingo-Domènech, R Molina, T Castel, et al.Endocrine-Related Cancer|May 27, 2006
Activation of nuclear factor-kappa B is linked to resistance to neoadjuvant chemotherapy in breast cancer patientsC Montagut, I Tusquets, B Ferrer, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 21, 2017
MRI assessment and outcomes in patients receiving neoadjuvant chemotherapy only for primary rectal cancer: long-term results from the GEMCAD 0801 trialU B Patel, G Brown, I Machado, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 10, 2015
Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomized trial†C Fernandez-Martos, X Garcia-Albeniz, C Pericay, et al.Pageof 2